Burning Rock Biotech (BNR) Operating Income (2020 - 2025)
Historic Operating Income for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to -$2.3 million.
- Burning Rock Biotech's Operating Income rose 5878.18% to -$2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$17.2 million, marking a year-over-year increase of 7212.2%. This contributed to the annual value of -$49.0 million for FY2024, which is 4803.6% up from last year.
- As of Q3 2025, Burning Rock Biotech's Operating Income stood at -$2.3 million, which was up 5878.18% from -$1.6 million recorded in Q2 2025.
- Burning Rock Biotech's Operating Income's 5-year high stood at -$1.6 million during Q2 2025, with a 5-year trough of -$41.5 million in Q1 2022.
- In the last 5 years, Burning Rock Biotech's Operating Income had a median value of -$24.5 million in 2023 and averaged -$22.0 million.
- In the last 5 years, Burning Rock Biotech's Operating Income tumbled by 20269.9% in 2021 and then surged by 8951.25% in 2025.
- Over the past 5 years, Burning Rock Biotech's Operating Income (Quarter) stood at -$39.6 million in 2021, then rose by 20.32% to -$31.5 million in 2022, then grew by 25.69% to -$23.4 million in 2023, then surged by 52.09% to -$11.2 million in 2024, then skyrocketed by 79.8% to -$2.3 million in 2025.
- Its Operating Income stands at -$2.3 million for Q3 2025, versus -$1.6 million for Q2 2025 and -$2.1 million for Q1 2025.